Abstract—It has not been clarified whether thresholds of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), soluble endoglin, and the sFlt-1/PlGF ratio for the imminent onset of preeclampsia (PE) exist. We hypothesized that onset thresholds for the imminent onset of PE could be determined by the distributions of these 4 markers just after the onset of PE. Study subjects were 51 PE after the onset of PE; 36 of PE, 20 of gestational hypertension, 142 of a small-for-gestational-age infant, and 400 of normal pregnant controls at 19 to 25 and 27 to 31 weeks of gestation in a prospective cohort study. The current data supported our hypothesis that onset thresholds of sFlt-1 and the sFlt-1/PlGF ratio exist. The onset thre...
Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng...
Objective: To test the hypothesis that preeclampsia (PE) can be predicted in primiparas early by mea...
BACKGROUND: Fetal growth restriction is a disorder of placental dysfunction with three to four-fold ...
Abstract—It has not been clarified whether thresholds of soluble fms-like tyrosine kinase 1 (sFlt-1)...
Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) contribute in the dev...
Objectives The soluble fms‐like tyrosine kinase‐1 (sFlt‐1) to placental growth factor (PlGF) ratio ...
We sought to assess the ratio of sFlt-1 (soluble fms-like tyrosine kinase 1) to PlGF (placental grow...
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevat...
Objectives: The soluble fm--s-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) rati...
Background. To assess the ability of mid-trimester sFlt-1/PlGF ratio for prediction of preeclampsia ...
Preeclampsia is a major cause of morbidity and mortality worldwide. Numerous candidate biomarkers ha...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
Objective: The aim of this study is to identify the role of sFlt-1/PIGF ratio as a prognostic marker...
Introduction: The objective was to investigate the diagnostic accuracy of different thresholds of th...
BACKGROUND: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble en...
Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng...
Objective: To test the hypothesis that preeclampsia (PE) can be predicted in primiparas early by mea...
BACKGROUND: Fetal growth restriction is a disorder of placental dysfunction with three to four-fold ...
Abstract—It has not been clarified whether thresholds of soluble fms-like tyrosine kinase 1 (sFlt-1)...
Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) contribute in the dev...
Objectives The soluble fms‐like tyrosine kinase‐1 (sFlt‐1) to placental growth factor (PlGF) ratio ...
We sought to assess the ratio of sFlt-1 (soluble fms-like tyrosine kinase 1) to PlGF (placental grow...
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevat...
Objectives: The soluble fm--s-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) rati...
Background. To assess the ability of mid-trimester sFlt-1/PlGF ratio for prediction of preeclampsia ...
Preeclampsia is a major cause of morbidity and mortality worldwide. Numerous candidate biomarkers ha...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
Objective: The aim of this study is to identify the role of sFlt-1/PIGF ratio as a prognostic marker...
Introduction: The objective was to investigate the diagnostic accuracy of different thresholds of th...
BACKGROUND: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble en...
Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng...
Objective: To test the hypothesis that preeclampsia (PE) can be predicted in primiparas early by mea...
BACKGROUND: Fetal growth restriction is a disorder of placental dysfunction with three to four-fold ...